KETOCONAZOLE CREAM, 2%

KETOCONAZOLE CREAM, 2% was reported 15184 times

These side effects are most commonly reported by patients taking KETOCONAZOLE CREAM, 2%:

# Side effect Count
0 DRUG INEFFECTIVE 1492
1 OFF LABEL USE 1134
2 PRURITUS 867
3 FATIGUE 863
4 RASH 765
5 NAUSEA 753
6 DIARRHOEA 719
7 HEADACHE 661
8 PAIN 635
9 PSORIASIS 612
10 DYSPNOEA 567
11 DIZZINESS 554
12 PRODUCT USE IN UNAPPROVED INDICATION 541
13 ARTHRALGIA 531
14 CHRONIC KIDNEY DISEASE 488
15 CONDITION AGGRAVATED 419
16 ANXIETY 417
17 FALL 399
18 ASTHENIA 398
19 PRODUCT DOSE OMISSION ISSUE 393
20 RENAL FAILURE 392
21 VOMITING 388
22 DRUG INTERACTION 379
23 DEATH 376
24 ERYTHEMA 359
25 ACUTE KIDNEY INJURY 355
26 PNEUMONIA 354
27 DRY SKIN 342
28 ALOPECIA 339
29 WEIGHT DECREASED 332
30 MALAISE 326
31 SKIN EXFOLIATION 324
32 COUGH 313
33 DEPRESSION 306
34 PAIN IN EXTREMITY 296
35 URINARY TRACT INFECTION 275
36 BACK PAIN 263
37 CONSTIPATION 263
38 INSOMNIA 262
39 PERIPHERAL SWELLING 258
40 PYREXIA 256
41 INJECTION SITE PAIN 230
42 PRODUCT USE ISSUE 224
43 DECREASED APPETITE 214
44 GAIT DISTURBANCE 210
45 MUSCLE SPASMS 206
46 TREMOR 202
47 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 201
48 ANAEMIA 200
49 HYPERTENSION 200
50 WEIGHT INCREASED 199
51 DERMATITIS ATOPIC 194
52 SOMNOLENCE 194
53 COVID-19 193
54 EMOTIONAL DISTRESS 190
55 HYPERSENSITIVITY 190
56 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 189
57 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 188
58 CHEST PAIN 184
59 FEELING ABNORMAL 184
60 ABDOMINAL PAIN 182
61 NASOPHARYNGITIS 175
62 HYPOTENSION 171
63 MYALGIA 169
64 INFECTION 168
65 MUSCULAR WEAKNESS 168
66 ABDOMINAL PAIN UPPER 163
67 DEHYDRATION 159
68 HYPOAESTHESIA 159
69 PARAESTHESIA 159
70 ECZEMA 156
71 URTICARIA 153
72 ABDOMINAL DISCOMFORT 152
73 ANHEDONIA 151
74 SINUSITIS 151
75 DRUG HYPERSENSITIVITY 150
76 OEDEMA PERIPHERAL 150
77 BLOOD PRESSURE INCREASED 148
78 CONFUSIONAL STATE 147
79 ADVERSE DRUG REACTION 142
80 NEUROPATHY PERIPHERAL 142
81 ASTHMA 141
82 SKIN IRRITATION 141
83 GASTROOESOPHAGEAL REFLUX DISEASE 138
84 LOSS OF CONSCIOUSNESS 138
85 END STAGE RENAL DISEASE 136
86 VISION BLURRED 135
87 TREATMENT FAILURE 133
88 PSORIATIC ARTHROPATHY 131
89 ARTHRITIS 125
90 MEMORY IMPAIRMENT 125
91 MIGRAINE 125
92 THROMBOCYTOPENIA 124
93 BLOOD GLUCOSE INCREASED 123
94 INCORRECT DOSE ADMINISTERED 123
95 ILLNESS 122
96 JOINT SWELLING 122
97 BURNING SENSATION 121
98 VISUAL IMPAIRMENT 118
99 DISEASE PROGRESSION 117
100 HYPOKALAEMIA 115
101 OROPHARYNGEAL PAIN 115
102 SEPSIS 115
103 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115
104 FUNGAL INFECTION 113
105 HOSPITALISATION 113
106 DYSPEPSIA 111
107 BALANCE DISORDER 110
108 HYPERHIDROSIS 109
109 CELLULITIS 108
110 HEART RATE INCREASED 108
111 SYNCOPE 108
112 PALPITATIONS 107
113 INFLUENZA 106
114 SWELLING 106
115 BRONCHITIS 105
116 HAIR TEXTURE ABNORMAL 105
117 SURGERY 105
118 CARDIAC FAILURE CONGESTIVE 104
119 SEIZURE 104
120 DYSPHAGIA 103
121 HALLUCINATION 103
122 THERAPEUTIC RESPONSE UNEXPECTED 102
123 DRY MOUTH 101
124 HOT FLUSH 101
125 SKIN BURNING SENSATION 99
126 ABDOMINAL DISTENSION 98
127 ECONOMIC PROBLEM 98
128 NEUTROPENIA 97
129 ACNE 96
130 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 96
131 GASTROINTESTINAL DISORDER 96
132 RASH PRURITIC 96
133 CEREBROVASCULAR ACCIDENT 95
134 CONTUSION 95
135 SLEEP DISORDER 94
136 DERMATITIS 93
137 EYE PAIN 93
138 SKIN DISORDER 93
139 ATRIAL FIBRILLATION 92
140 DRY EYE 92
141 SWELLING FACE 92
142 BLOOD CREATININE INCREASED 91
143 HAEMOGLOBIN DECREASED 91
144 RASH ERYTHEMATOUS 91
145 RHABDOMYOLYSIS 91
146 BLISTER 87
147 NEPHROGENIC ANAEMIA 86
148 PRODUCT DOSE OMISSION 86
149 RENAL IMPAIRMENT 86
150 RHINORRHOEA 86
151 TACHYCARDIA 85
152 ACCIDENTAL EXPOSURE TO PRODUCT 84
153 CHILLS 84
154 DRUG INTOLERANCE 84
155 SKIN LESION 84
156 SUICIDAL IDEATION 84
157 HEPATIC ENZYME INCREASED 83
158 OSTEOARTHRITIS 83
159 SEBORRHOEIC DERMATITIS 83
160 ALANINE AMINOTRANSFERASE INCREASED 82
161 CHEST DISCOMFORT 82
162 PULMONARY EMBOLISM 82
163 EYE IRRITATION 81
164 INJECTION SITE ERYTHEMA 81
165 MUSCULOSKELETAL STIFFNESS 81
166 THERAPY NON-RESPONDER 81
167 UNEVALUABLE EVENT 81
168 SKIN DISCOLOURATION 80
169 ADRENAL INSUFFICIENCY 79
170 ASPARTATE AMINOTRANSFERASE INCREASED 79
171 OEDEMA 79
172 OSTEOPOROSIS 79
173 PROSTATIC SPECIFIC ANTIGEN INCREASED 79
174 DYSPHONIA 78
175 DRUG DOSE OMISSION 77
176 NASAL CONGESTION 77
177 PRODUCT QUALITY ISSUE 77
178 MYOCARDIAL INFARCTION 76
179 THERAPEUTIC RESPONSE DECREASED 76
180 THERAPY INTERRUPTED 76
181 EPISTAXIS 75
182 OCULAR HYPERAEMIA 75
183 STRESS 75
184 THERAPEUTIC RESPONSE SHORTENED 75
185 MOBILITY DECREASED 74
186 DIABETES MELLITUS 72
187 NEPHROLITHIASIS 72
188 SLEEP APNOEA SYNDROME 72
189 WHITE BLOOD CELL COUNT DECREASED 72
190 CARDIAC DISORDER 71
191 INTENTIONAL PRODUCT USE ISSUE 71
192 MALIGNANT NEOPLASM PROGRESSION 70
193 PLATELET COUNT DECREASED 70
194 CATARACT 69
195 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 69
196 UPPER RESPIRATORY TRACT INFECTION 69
197 VERTIGO 69
198 BONE DENSITY DECREASED 68
199 PRODUCTIVE COUGH 68
200 RENAL INJURY 68
201 INJURY 67
202 OXYGEN SATURATION DECREASED 66
203 ADVERSE EVENT 65
204 CONTRAINDICATED PRODUCT ADMINISTERED 65
205 GENERAL PHYSICAL HEALTH DETERIORATION 65
206 HAIR COLOUR CHANGES 65
207 HEPATOTOXICITY 65
208 HERPES ZOSTER 65
209 RENAL FAILURE ACUTE 65
210 GASTROINTESTINAL HAEMORRHAGE 64
211 NO ADVERSE EVENT 64
212 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 64
213 BLOOD PRESSURE DECREASED 63
214 RASH MACULAR 63
215 BONE PAIN 62
216 PAPULE 62
217 THROMBOSIS 62
218 HAEMORRHAGE 61
219 INJECTION SITE BRUISING 61
220 INJECTION SITE SWELLING 61
221 SINUS DISORDER 61
222 STOMATITIS 61
223 AGITATION 60
224 APPLICATION SITE PAIN 60
225 DISCOMFORT 60
226 EYE PRURITUS 60
227 AMNESIA 59
228 DEEP VEIN THROMBOSIS 59
229 NECK PAIN 59
230 WHEEZING 59
231 INFLAMMATION 58
232 PLEURAL EFFUSION 58
233 RHEUMATOID ARTHRITIS 58
234 URINARY INCONTINENCE 58
235 BLOOD CHOLESTEROL INCREASED 57
236 ERECTILE DYSFUNCTION 57
237 FLUSHING 57
238 HYPERKALAEMIA 57
239 OSTEOPENIA 57
240 POLLAKIURIA 57
241 PRODUCT ADMINISTRATION INTERRUPTED 57
242 SKIN FISSURES 57
243 SKIN ULCER 57
244 DYSPNOEA EXERTIONAL 56
245 FEBRILE NEUTROPENIA 56
246 INTENTIONAL PRODUCT MISUSE 56
247 RESPIRATORY FAILURE 56
248 TINNITUS 56
249 SKIN PLAQUE 55
250 INJECTION SITE PRURITUS 54
251 LEUKOPENIA 54
252 DYSGEUSIA 53
253 FLUID RETENTION 53
254 LUNG DISORDER 53
255 PAIN OF SKIN 53
256 ARTHROPATHY 52
257 COGNITIVE DISORDER 52
258 DANDRUFF 52
259 FLATULENCE 52
260 HYPOGLYCAEMIA 52
261 OVERDOSE 52
262 SCAB 52
263 MATERNAL EXPOSURE DURING PREGNANCY 51
264 BRADYCARDIA 50
265 LETHARGY 50
266 SEPTIC SHOCK 50
267 THERAPEUTIC PRODUCT EFFECT DECREASED 50
268 CARDIAC ARREST 49
269 CYSTITIS 49
270 HYPERPARATHYROIDISM SECONDARY 49
271 DRUG-INDUCED LIVER INJURY 48
272 INFLUENZA LIKE ILLNESS 48
273 SKIN HAEMORRHAGE 48
274 STAPHYLOCOCCAL INFECTION 48
275 TREATMENT NONCOMPLIANCE 48
276 APPLICATION SITE PRURITUS 47
277 BLOOD ALKALINE PHOSPHATASE INCREASED 47
278 BONE DISORDER 47
279 DYSURIA 47
280 EAR INFECTION 47
281 HYPOTHYROIDISM 47
282 OSTEONECROSIS 47
283 THROAT IRRITATION 47
284 BLOOD POTASSIUM DECREASED 46
285 CHOLELITHIASIS 46
286 DEPRESSED MOOD 46
287 FEELING HOT 46
288 HYPERLIPIDAEMIA 46
289 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 46
290 LOCALISED INFECTION 46
291 MUSCULOSKELETAL PAIN 46
292 ELECTROCARDIOGRAM QT PROLONGED 45
293 INFUSION RELATED REACTION 45
294 LIVER FUNCTION TEST ABNORMAL 45
295 SEASONAL ALLERGY 45
296 INTENTIONAL DOSE OMISSION 44
297 NIGHT SWEATS 44
298 SPEECH DISORDER 44
299 APPLICATION SITE ERYTHEMA 43
300 LIVER DISORDER 43
301 OSTEONECROSIS OF JAW 43
302 DERMATITIS CONTACT 42
303 EYE DISORDER 42
304 INTESTINAL OBSTRUCTION 42
305 MENTAL STATUS CHANGES 42
306 HYPOXIA 41
307 LIMB INJURY 41
308 SKIN INFECTION 41
309 TOXICITY TO VARIOUS AGENTS 41
310 TUBULOINTERSTITIAL NEPHRITIS 41
311 BLOOD GLUCOSE DECREASED 40
312 DEAFNESS 40
313 DYSKINESIA 40
314 LACRIMATION INCREASED 40
315 OSTEOMYELITIS 40
316 PAIN IN JAW 40
317 RIB FRACTURE 40
318 DEVICE ISSUE 39
319 HAEMATURIA 39
320 LIMB DISCOMFORT 39
321 MENTAL DISORDER 39
322 PANIC ATTACK 39
323 THERAPY PARTIAL RESPONDER 39
324 BACTERIAL INFECTION 38
325 CORONARY ARTERY DISEASE 38
326 HYPERSOMNIA 38
327 INTERVERTEBRAL DISC PROTRUSION 38
328 METASTASES TO BONE 38
329 ORTHOSTATIC HYPOTENSION 38
330 SPINAL OSTEOARTHRITIS 38
331 SWOLLEN TONGUE 38
332 THERAPY CESSATION 38
333 URINARY RETENTION 38
334 ACUTE MYOCARDIAL INFARCTION 37
335 BLOOD SODIUM DECREASED 37
336 CHROMATURIA 37
337 DISTURBANCE IN ATTENTION 37
338 EYE SWELLING 37
339 IMPAIRED GASTRIC EMPTYING 37
340 LYMPHADENOPATHY 37
341 MOUTH ULCERATION 37
342 PRODUCT DOSE OMISSION IN ERROR 37
343 RENAL DISORDER 37
344 TRANSIENT ISCHAEMIC ATTACK 37
345 ABNORMAL BEHAVIOUR 36
346 ANAPHYLACTIC REACTION 36
347 DYSARTHRIA 36
348 FOOT FRACTURE 36
349 HEPATITIS 36
350 IMPAIRED HEALING 36
351 NERVOUSNESS 36
352 PANCYTOPENIA 36
353 PRE-EXISTING CONDITION IMPROVED 36
354 PROSTATE CANCER 36
355 UNDERDOSE 36
356 CARDIAC FAILURE 35
357 CONJUNCTIVITIS 35
358 FUNGAL SKIN INFECTION 35
359 HAEMORRHOIDS 35
360 HEART RATE DECREASED 35
361 HYPONATRAEMIA 35
362 IRRITABILITY 35
363 MULTIPLE SCLEROSIS RELAPSE 35
364 PARKINSON^S DISEASE 35
365 RENAL TUBULAR NECROSIS 35
366 SYSTEMIC LUPUS ERYTHEMATOSUS 35
367 GAIT INABILITY 34
368 INJECTION SITE REACTION 34
369 LIP SWELLING 34
370 SPUTUM DISCOLOURED 34
371 WHITE BLOOD CELL COUNT INCREASED 34
372 WOUND 34
373 BASAL CELL CARCINOMA 33
374 BRAIN FOG 33
375 HYPOPHAGIA 33
376 INTERNATIONAL NORMALISED RATIO INCREASED 33
377 NEURALGIA 33
378 ORAL HERPES 33
379 PANCREATITIS 33
380 POOR QUALITY SLEEP 33
381 SCAR 33
382 TOOTH DISORDER 33
383 TYPE 2 DIABETES MELLITUS 33
384 BLOOD BILIRUBIN INCREASED 32
385 CROHN^S DISEASE 32
386 EOSINOPHILIA 32
387 HAEMATOCHEZIA 32
388 HEAD INJURY 32
389 HEPATIC FAILURE 32
390 HYPERGLYCAEMIA 32
391 ORAL PAIN 32
392 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32
393 RED BLOOD CELL COUNT DECREASED 32
394 VITAMIN D DEFICIENCY 32
395 DRUG EFFECT DECREASED 31
396 GASTRITIS 31
397 IRRITABLE BOWEL SYNDROME 31
398 MUSCULOSKELETAL DISCOMFORT 31
399 NEOPLASM MALIGNANT 31
400 NODULE 31
401 SEBORRHOEIC KERATOSIS 31
402 TOOTH INFECTION 31
403 TRANSAMINASES INCREASED 31
404 ANGIOEDEMA 30
405 CORTISOL INCREASED 30
406 DRUG RESISTANCE 30
407 EXPOSURE DURING PREGNANCY 30
408 FIBROMYALGIA 30
409 GLAUCOMA 30
410 NOCTURIA 30
411 REBOUND ACID HYPERSECRETION 30
412 TENDERNESS 30
413 CARDIO-RESPIRATORY ARREST 29
414 HIDRADENITIS 29
415 HYPOACUSIS 29
416 INTERVERTEBRAL DISC DEGENERATION 29
417 LIVER FUNCTION TEST INCREASED 29
418 MOVEMENT DISORDER 29
419 NEUTROPHIL COUNT DECREASED 29
420 PHOTOPHOBIA 29
421 RASH PAPULAR 29
422 SCRATCH 29
423 SKIN LACERATION 29
424 TOOTHACHE 29
425 ACTINIC KERATOSIS 28
426 ANKLE FRACTURE 28
427 DIPLOPIA 28
428 DIVERTICULITIS 28
429 EAR PAIN 28
430 ELECTROLYTE IMBALANCE 28
431 EXPOSURE VIA SKIN CONTACT 28
432 FULL BLOOD COUNT ABNORMAL 28
433 HAEMATOCRIT DECREASED 28
434 JAW FRACTURE 28
435 PHOTOSENSITIVITY REACTION 28
436 PNEUMONIA ASPIRATION 28
437 RESPIRATORY TRACT INFECTION 28
438 RESTLESSNESS 28
439 SKIN HYPERPIGMENTATION 28
440 TOOTH LOSS 28
441 VIRAL INFECTION 28
442 ARRHYTHMIA 27
443 BLOOD POTASSIUM INCREASED 27
444 CONVULSION 27
445 DENTAL CARIES 27
446 DISORIENTATION 27
447 DIVERTICULUM 27
448 DRUG EFFECT LESS THAN EXPECTED 27
449 FEELING COLD 27
450 HAEMOPTYSIS 27
451 HEPATIC CIRRHOSIS 27
452 INTERTRIGO 27
453 JAUNDICE 27
454 JOINT STIFFNESS 27
455 MELANOCYTIC NAEVUS 27
456 NAIL DISORDER 27
457 NERVE INJURY 27
458 OBESITY 27
459 PULMONARY MASS 27
460 RESTLESS LEGS SYNDROME 27
461 SENSORY DISTURBANCE 27
462 SKIN PAPILLOMA 27
463 TINEA PEDIS 27
464 WITHDRAWAL SYNDROME 27
465 ACCIDENTAL OVERDOSE 26
466 AGGRESSION 26
467 DRUG LEVEL INCREASED 26
468 HAEMATOMA 26
469 INJECTION SITE HAEMORRHAGE 26
470 MOOD ALTERED 26
471 PLASMA CELL MYELOMA 26
472 PRESYNCOPE 26
473 PRODUCT PRESCRIBING ISSUE 26
474 ROSACEA 26
475 ROTATOR CUFF SYNDROME 26
476 TARDIVE DYSKINESIA 26
477 TASTE DISORDER 26
478 THROAT TIGHTNESS 26
479 TRICHORRHEXIS 26
480 AGEUSIA 25
481 BLOOD PRESSURE ABNORMAL 25
482 BONE LOSS 25
483 COLITIS 25
484 EYE DISCHARGE 25
485 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25
486 HEPATIC FUNCTION ABNORMAL 25
487 HEPATIC STEATOSIS 25
488 HIP FRACTURE 25
489 NEPHROPATHY 25
490 PULMONARY OEDEMA 25
491 PUSTULE 25
492 RENAL CYST 25
493 SKIN SWELLING 25
494 UPPER-AIRWAY COUGH SYNDROME 25
495 APPLICATION SITE IRRITATION 24
496 ARTERIOSCLEROSIS 24
497 CANDIDA INFECTION 24
498 CLOSTRIDIUM DIFFICILE INFECTION 24
499 DRUG DEPENDENCE 24
500 DYSSTASIA 24
501 EYE INFECTION 24
502 GALLBLADDER DISORDER 24
503 HALLUCINATION, VISUAL 24
504 HYPERKERATOSIS 24
505 ILL-DEFINED DISORDER 24
506 JOINT INJURY 24
507 PRODUCT PHYSICAL ISSUE 24
508 PROSTATE CANCER METASTATIC 24
509 RECTAL HAEMORRHAGE 24
510 RESPIRATORY DISTRESS 24
511 RETCHING 24
512 RHINITIS ALLERGIC 24
513 ROAD TRAFFIC ACCIDENT 24
514 SKIN WEEPING 24
515 SNEEZING 24
516 AFFECTIVE DISORDER 23
517 ATELECTASIS 23
518 BENIGN PROSTATIC HYPERPLASIA 23
519 CYST 23
520 DECREASED ACTIVITY 23
521 DELIRIUM 23
522 DEMENTIA 23
523 DISABILITY 23
524 EATING DISORDER 23
525 EXPIRED PRODUCT ADMINISTERED 23
526 FOLLICULITIS 23
527 HEART RATE IRREGULAR 23
528 LIBIDO DECREASED 23
529 METABOLIC ACIDOSIS 23
530 MULTIPLE ALLERGIES 23
531 PULMONARY FIBROSIS 23
532 SCIATICA 23
533 SUICIDE ATTEMPT 23
534 SWELLING OF EYELID 23
535 TOOTH ABSCESS 23
536 ABNORMAL DREAMS 22
537 ACUTE RESPIRATORY FAILURE 22
538 CARDIAC MURMUR 22
539 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22
540 DISEASE RECURRENCE 22
541 FAECES DISCOLOURED 22
542 MITRAL VALVE INCOMPETENCE 22
543 MUCOSAL INFLAMMATION 22
544 MULTIPLE SCLEROSIS 22
545 PNEUMOTHORAX 22
546 PRODUCT LABEL ISSUE 22
547 PRODUCT SUBSTITUTION ISSUE 22
548 PROTEINURIA 22
549 PULMONARY HYPERTENSION 22
550 QUALITY OF LIFE DECREASED 22
551 SINUS CONGESTION 22
552 SKIN MASS 22
553 ANGINA PECTORIS 21
554 APHASIA 21
555 BLOOD PRESSURE FLUCTUATION 21
556 C-REACTIVE PROTEIN INCREASED 21
557 FEEDING DISORDER 21
558 FURUNCLE 21
559 GLYCOSYLATED HAEMOGLOBIN INCREASED 21
560 GOUT 21
561 INFUSION SITE PAIN 21
562 MUSCLE TWITCHING 21
563 NERVOUS SYSTEM DISORDER 21
564 RASH GENERALISED 21
565 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21
566 RESPIRATORY DISORDER 21
567 SLUGGISHNESS 21
568 XEROSIS 21
569 CHEST X-RAY ABNORMAL 20
570 CHOLESTASIS 20
571 COLITIS ULCERATIVE 20
572 DERMATITIS ALLERGIC 20
573 DEVICE MALFUNCTION 20
574 FULL BLOOD COUNT DECREASED 20
575 GASTRIC DISORDER 20
576 GASTROENTERITIS 20
577 HERPES VIRUS INFECTION 20
578 HYPOAESTHESIA ORAL 20
579 INCREASED TENDENCY TO BRUISE 20
580 MICTURITION URGENCY 20
581 NIGHTMARE 20
582 PALLOR 20
583 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20
584 PHARYNGITIS 20
585 PRODUCT USE COMPLAINT 20
586 SECRETION DISCHARGE 20
587 ABSCESS 19
588 ACUTE RESPIRATORY DISTRESS SYNDROME 19
589 AORTIC ARTERIOSCLEROSIS 19
590 ARTERIOSCLEROSIS CORONARY ARTERY 19
591 BACK DISORDER 19
592 BRADYKINESIA 19
593 CARDIOMEGALY 19
594 CARPAL TUNNEL SYNDROME 19
595 COAGULOPATHY 19
596 DELUSION 19
597 EXOSTOSIS 19
598 FREQUENT BOWEL MOVEMENTS 19
599 GASTROENTERITIS VIRAL 19
600 GINGIVITIS 19
601 HOSPICE CARE 19
602 IMPETIGO 19
603 INCORRECT PRODUCT ADMINISTRATION DURATION 19
604 INSURANCE ISSUE 19
605 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 19
606 LEG AMPUTATION 19
607 LIGAMENT SPRAIN 19
608 LIVER INJURY 19
609 NEUTROPENIC SEPSIS 19
610 PARANOIA 19
611 PATHOGEN RESISTANCE 19
612 PHARYNGEAL OEDEMA 19
613 PIGMENTATION DISORDER 19
614 PRODUCT STORAGE ERROR 19
615 PSEUDOMONAS INFECTION 19
616 SPINAL OPERATION 19
617 TRICUSPID VALVE INCOMPETENCE 19
618 VAGINAL HAEMORRHAGE 19
619 ARTHROPOD BITE 18
620 BIPOLAR DISORDER 18
621 BLOOD CREATINE PHOSPHOKINASE INCREASED 18
622 BLOOD PRESSURE SYSTOLIC INCREASED 18
623 BREAST CANCER 18
624 CARDIOMYOPATHY 18
625 CONTRAINDICATION TO MEDICAL TREATMENT 18
626 COORDINATION ABNORMAL 18
627 COVID-19 PNEUMONIA 18
628 CUSHING^S SYNDROME 18
629 DYSTONIA 18
630 GASTRIC ULCER 18
631 GYNAECOMASTIA 18
632 HYPERCHOLESTEROLAEMIA 18
633 INFUSION SITE ERYTHEMA 18
634 LUNG NEOPLASM MALIGNANT 18
635 MIDDLE INSOMNIA 18
636 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18
637 MUSCLE TIGHTNESS 18
638 NEOPLASM 18
639 NEUROTOXICITY 18
640 PERIORBITAL SWELLING 18
641 PETECHIAE 18
642 PNEUMOCYSTIS JIROVECII PNEUMONIA 18
643 PRODUCT PHYSICAL CONSISTENCY ISSUE 18
644 RASH MACULO-PAPULAR 18
645 RENAL FAILURE CHRONIC 18
646 SINUS BRADYCARDIA 18
647 SKIN CANCER 18
648 SUPRAVENTRICULAR TACHYCARDIA 18
649 THYROID DISORDER 18
650 TOXIC EPIDERMAL NECROLYSIS 18
651 VENTRICULAR EXTRASYSTOLES 18
652 ABORTION SPONTANEOUS 17
653 BLOOD TESTOSTERONE DECREASED 17
654 BLOOD UREA INCREASED 17
655 BURSITIS 17
656 EJECTION FRACTION DECREASED 17
657 EXTRA DOSE ADMINISTERED 17
658 FEAR 17
659 HEAD DISCOMFORT 17
660 HIATUS HERNIA 17
661 HYPERTRIGLYCERIDAEMIA 17
662 IMPAIRED QUALITY OF LIFE 17
663 INJECTION SITE MASS 17
664 INJECTION SITE URTICARIA 17
665 KIDNEY INFECTION 17
666 LEUKOCYTOSIS 17
667 LUNG INFILTRATION 17
668 MASS 17
669 MULTIPLE FRACTURES 17
670 ONYCHOMYCOSIS 17
671 ORAL CANDIDIASIS 17
672 POST PROCEDURAL COMPLICATION 17
673 PRODUCT ADMINISTRATION ERROR 17
674 PSYCHOTIC DISORDER 17
675 SCOLIOSIS 17
676 SEBORRHOEA 17
677 SENSITIVE SKIN 17
678 SKIN REACTION 17
679 THROMBOPHLEBITIS SUPERFICIAL 17
680 TOOTH FRACTURE 17
681 VENTRICULAR TACHYCARDIA 17
682 VERTIGO POSITIONAL 17
683 VITREOUS FLOATERS 17
684 ANGER 16
685 BLOOD GLUCOSE ABNORMAL 16
686 BLOOD IMMUNOGLOBULIN E INCREASED 16
687 BLOOD URINE PRESENT 16
688 BODY HEIGHT DECREASED 16
689 BONE LESION 16
690 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16
691 CONCUSSION 16
692 CRYING 16
693 DIABETIC NEUROPATHY 16
694 DIALYSIS 16
695 EMOTIONAL DISORDER 16
696 EMPHYSEMA 16
697 FOOD ALLERGY 16
698 HAIR GROWTH ABNORMAL 16
699 HALLUCINATION, AUDITORY 16
700 HEPATIC CYTOLYSIS 16
701 HYDRONEPHROSIS 16
702 INJECTION SITE DISCOLOURATION 16
703 INJECTION SITE RASH 16
704 JAW DISORDER 16
705 KNEE ARTHROPLASTY 16
706 LOWER RESPIRATORY TRACT INFECTION 16
707 MALIGNANT MELANOMA 16
708 MIXED LIVER INJURY 16
709 MULTIPLE INJURIES 16
710 NEOPLASM PROGRESSION 16
711 NO THERAPEUTIC RESPONSE 16
712 OBSESSIVE-COMPULSIVE DISORDER 16
713 OESOPHAGITIS 16
714 ONYCHOCLASIS 16
715 ORAL DISORDER 16
716 OTITIS MEDIA 16
717 OTITIS MEDIA ACUTE 16
718 PLATELET COUNT INCREASED 16
719 PRESCRIBED UNDERDOSE 16
720 PRODUCT PRESCRIBING ERROR 16
721 SKIN ABRASION 16
722 SMALL INTESTINAL OBSTRUCTION 16
723 SPINAL FRACTURE 16
724 THINKING ABNORMAL 16
725 VASCULITIS 16
726 ACTIVITIES OF DAILY LIVING IMPAIRED 15
727 AGRANULOCYTOSIS 15
728 ASPERGILLUS TEST POSITIVE 15
729 BLOOD CHLORIDE DECREASED 15
730 BODY TEMPERATURE INCREASED 15
731 BRONCHOSPASM 15
732 COLD SWEAT 15
733 DECUBITUS ULCER 15
734 DERMATITIS ACNEIFORM 15
735 DRUG EFFECT INCOMPLETE 15
736 DRUG WITHDRAWAL SYNDROME 15
737 ENCEPHALOPATHY 15
738 FAILURE TO THRIVE 15
739 FEELING JITTERY 15
740 FRACTURE 15
741 GENERALISED OEDEMA 15
742 GENERALISED TONIC-CLONIC SEIZURE 15
743 GINGIVAL PAIN 15
744 HAIR DISORDER 15
745 HAND FRACTURE 15
746 HEPATOCELLULAR INJURY 15
747 ILEUS 15
748 IMMUNE SYSTEM DISORDER 15
749 INITIAL INSOMNIA 15
750 INJECTION SITE WARMTH 15
751 JOINT EFFUSION 15
752 LABORATORY TEST ABNORMAL 15
753 LOOSE TOOTH 15
754 LYMPHOCYTE COUNT DECREASED 15
755 LYMPHOMA 15
756 PERICARDIAL EFFUSION 15
757 PHARYNGEAL SWELLING 15
758 PNEUMONITIS 15
759 SUBCUTANEOUS ABSCESS 15
760 THERAPEUTIC PRODUCT INEFFECTIVE 15
761 THIRST 15
762 ULCER 15
763 ABDOMINAL PAIN LOWER 14
764 APPLICATION SITE RASH 14
765 ASCITES 14
766 ATRIAL FLUTTER 14
767 AUTOIMMUNE DISORDER 14
768 BEDRIDDEN 14
769 BLOOD IRON DECREASED 14
770 BREAST MASS 14
771 CEREBRAL HAEMORRHAGE 14
772 CHRONIC SINUSITIS 14
773 DEPRESSED LEVEL OF CONSCIOUSNESS 14
774 DIABETIC KETOACIDOSIS 14
775 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14
776 DRUG ERUPTION 14
777 EPILEPSY 14
778 FISTULA 14
779 FOOT DEFORMITY 14
780 HICCUPS 14
781 HUNGER 14
782 HYPOCALCAEMIA 14
783 HYPOPHOSPHATAEMIA 14
784 IMMUNODEFICIENCY 14
785 IMPAIRED WORK ABILITY 14
786 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14
787 INFUSION SITE EXTRAVASATION 14
788 INJECTION SITE DISCOMFORT 14
789 INTERSTITIAL LUNG DISEASE 14
790 JOINT DISLOCATION 14
791 LENTIGO 14
792 LIP PAIN 14
793 LUMBAR SPINAL STENOSIS 14
794 LYMPHOEDEMA 14
795 MACULE 14
796 MAJOR DEPRESSION 14
797 MANIA 14
798 MENTAL IMPAIRMENT 14
799 METASTASES TO LUNG 14
800 MUSCLE SPASTICITY 14
801 MUSCULOSKELETAL CHEST PAIN 14
802 OCULAR DISCOMFORT 14
803 ORAL DISCOMFORT 14
804 PELVIC PAIN 14
805 PNEUMONIA BACTERIAL 14
806 PRODUCT DISTRIBUTION ISSUE 14
807 PRODUCT PACKAGING ISSUE 14
808 PURULENT DISCHARGE 14
809 REBOUND EFFECT 14
810 SKIN HYPERTROPHY 14
811 SPINAL PAIN 14
812 SQUAMOUS CELL CARCINOMA 14
813 STEVENS-JOHNSON SYNDROME 14
814 TEMPERATURE INTOLERANCE 14
815 THERMAL BURN 14
816 UPPER LIMB FRACTURE 14
817 VESTIBULAR DISORDER 14
818 VITAMIN D DECREASED 14
819 WRIST FRACTURE 14
820 ABASIA 13
821 ABSCESS LIMB 13
822 APPLICATION SITE SWELLING 13
823 BLOOD CREATININE DECREASED 13
824 BODY TINEA 13
825 CHOLECYSTECTOMY 13
826 CLOSTRIDIUM DIFFICILE COLITIS 13
827 COMPLICATION ASSOCIATED WITH DEVICE 13
828 COMPRESSION FRACTURE 13
829 DEAFNESS BILATERAL 13
830 DERMATITIS PSORIASIFORM 13
831 DEVICE RELATED INFECTION 13
832 DRUG PRESCRIBING ERROR 13
833 EAR DISCOMFORT 13
834 ECCHYMOSIS 13
835 EXTRAPYRAMIDAL DISORDER 13
836 FEMUR FRACTURE 13
837 HAEMATEMESIS 13
838 HEPATITIS FULMINANT 13
839 HERNIA 13
840 INCORRECT DRUG ADMINISTRATION DURATION 13
841 INFUSION SITE SWELLING 13
842 IRON DEFICIENCY ANAEMIA 13
843 LARYNGITIS 13
844 LOW DENSITY LIPOPROTEIN INCREASED 13
845 LUNG CONSOLIDATION 13
846 LYMPHOPENIA 13
847 MEDICATION ERROR 13
848 METASTASES TO LIVER 13
849 MYOSITIS 13
850 NERVE COMPRESSION 13
851 PARAESTHESIA ORAL 13
852 PERFORMANCE STATUS DECREASED 13
853 PNEUMONIA MYCOPLASMAL 13
854 POST-TRAUMATIC STRESS DISORDER 13
855 PRODUCT PREPARATION ERROR 13
856 PRURITUS GENERALISED 13
857 PSYCHOMOTOR HYPERACTIVITY 13
858 RASH PUSTULAR 13
859 RESPIRATORY TRACT CONGESTION 13
860 SEDATION 13
861 SPINAL DISORDER 13
862 SPINAL FUSION SURGERY 13
863 SPLENOMEGALY 13
864 TOOTH EXTRACTION 13
865 UPPER GASTROINTESTINAL HAEMORRHAGE 13
866 ADRENOCORTICAL INSUFFICIENCY ACUTE 12
867 ANAL INCONTINENCE 12
868 AORTIC ANEURYSM 12
869 APHONIA 12
870 BACTERIAL TEST POSITIVE 12
871 BLINDNESS 12
872 BLOOD MAGNESIUM DECREASED 12
873 BONE DEMINERALISATION 12
874 BOWEL MOVEMENT IRREGULARITY 12
875 BREAST PAIN 12
876 CENTRAL NERVOUS SYSTEM LESION 12
877 CRYPTOCOCCOSIS 12
878 DIABETES MELLITUS INADEQUATE CONTROL 12
879 DIZZINESS POSTURAL 12
880 DRUG EXPOSURE DURING PREGNANCY 12
881 ESSENTIAL HYPERTENSION 12
882 FACIAL PAIN 12
883 FEELING DRUNK 12
884 FOOD POISONING 12
885 FORMICATION 12
886 GLOSSODYNIA 12
887 HYPERCALCAEMIA 12
888 HYPOALBUMINAEMIA 12
889 HYPOMAGNESAEMIA 12
890 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 12
891 INTENTIONAL OVERDOSE 12
892 LIP DRY 12
893 LOWER LIMB FRACTURE 12
894 MENISCUS INJURY 12
895 METASTASES TO SPINE 12
896 MUSCULOSKELETAL DISORDER 12
897 MYCOBACTERIUM AVIUM COMPLEX INFECTION 12
898 MYDRIASIS 12
899 NOSOCOMIAL INFECTION 12
900 OBSTRUCTIVE SLEEP APNOEA SYNDROME 12
901 OSTEITIS 12
902 OVARIAN CYST 12
903 PANCREATITIS ACUTE 12
904 PERIPHERAL VASCULAR DISORDER 12
905 PERITONITIS 12
906 PITUITARY-DEPENDENT CUSHING^S SYNDROME 12
907 POSTOPERATIVE WOUND INFECTION 12
908 PRODUCT AVAILABILITY ISSUE 12
909 PRODUCT RESIDUE PRESENT 12
910 PSYCHOLOGICAL TRAUMA 12
911 PULMONARY CONGESTION 12
912 PULMONARY GRANULOMA 12
913 PULMONARY HAEMORRHAGE 12
914 PURPURA SENILE 12
915 SINUS TACHYCARDIA 12
916 SUNBURN 12
917 TARSAL TUNNEL SYNDROME 12
918 TENDONITIS 12
919 TINEA CRURIS 12
920 TINEA VERSICOLOUR 12
921 VISUAL ACUITY REDUCED 12
922 ABNORMAL FAECES 11
923 ADRENAL SUPPRESSION 11
924 APPLICATION SITE DISCOLOURATION 11
925 APPLICATION SITE DRYNESS 11
926 APPLICATION SITE EXFOLIATION 11
927 APPLICATION SITE VESICLES 11
928 ATRIOVENTRICULAR BLOCK COMPLETE 11
929 BACK INJURY 11
930 BLINDNESS UNILATERAL 11
931 BODY TEMPERATURE DECREASED 11
932 CHEMICAL BURN 11
933 CHOKING 11
934 CHOLECYSTITIS 11
935 CLOSTRIDIUM TEST POSITIVE 11
936 CORONARY ARTERY OCCLUSION 11
937 CYSTITIS HAEMORRHAGIC 11
938 DERMAL CYST 11
939 DEVICE LEAKAGE 11
940 DIVERTICULUM INTESTINAL 11
941 DROOLING 11
942 ERUCTATION 11
943 FLANK PAIN 11
944 FOETAL EXPOSURE DURING PREGNANCY 11
945 GASTROINTESTINAL INFECTION 11
946 GUTTATE PSORIASIS 11
947 IMPAIRED DRIVING ABILITY 11
948 INCONTINENCE 11
949 INFUSION SITE HAEMORRHAGE 11
950 INJECTION SITE VESICLES 11
951 INTENTIONAL SELF-INJURY 11
952 LOCAL SWELLING 11
953 MOOD SWINGS 11
954 MOUTH SWELLING 11
955 NEEDLE ISSUE 11
956 NEURODERMATITIS 11
957 NORMOCHROMIC NORMOCYTIC ANAEMIA 11
958 OROPHARYNGEAL DISCOMFORT 11
959 PHOTOPSIA 11
960 PRODUCT COLOUR ISSUE 11
961 PRODUCT DISPENSING ERROR 11
962 PRODUCT ODOUR ABNORMAL 11
963 PROSTATOMEGALY 11
964 PRURITUS GENITAL 11
965 RAYNAUD^S PHENOMENON 11
966 RESORPTION BONE INCREASED 11
967 SALIVARY HYPERSECRETION 11
968 SENSORY LOSS 11
969 UROSEPSIS 11
970 ABNORMAL LOSS OF WEIGHT 10
971 ANAPHYLACTIC SHOCK 10
972 ANEURYSM 10
973 ANOREXIA 10
974 APHTHOUS ULCER 10
975 BLINDNESS TRANSIENT 10
976 BRAIN INJURY 10
977 CARDIOVASCULAR DISORDER 10
978 COLON CANCER 10
979 DEFORMITY 10
980 DIASTOLIC DYSFUNCTION 10
981 DRUG ADMINISTERED AT INAPPROPRIATE SITE 10
982 DRUG DOSE OMISSION BY DEVICE 10
983 ELECTROCARDIOGRAM ABNORMAL 10
984 ERYTHEMA MULTIFORME 10
985 ERYTHEMA OF EYELID 10
986 GINGIVAL BLEEDING 10
987 GLUCOSE TOLERANCE IMPAIRED 10
988 HEPATITIS CHOLESTATIC 10
989 HEPATOMEGALY 10
990 HEPATOSPLENOMEGALY 10
991 HYPERTRANSAMINASAEMIA 10
992 HYPOGONADISM 10
993 IDIOPATHIC INTRACRANIAL HYPERTENSION 10
994 INCOHERENT 10
995 INTRAOCULAR PRESSURE INCREASED 10
996 LEFT VENTRICULAR HYPERTROPHY 10
997 MACULAR DEGENERATION 10
998 MENINGITIS ASEPTIC 10
999 MUSCLE ATROPHY 10